France is the European country with the highest tax burden for pharmaceutical companies, according to a study published on Thursday (May 2) by Entreprises du Médicament en France (Leem), an association of French pharmaceutical companies.
The study, commissioned by Leem from consulting firm PwC, looked at tax policy in seven European countries: Germany, Italy, the United-Kingdom, Ireland, Spain, Switzerland, and France.
“In 2023, two…
